Related Experiment Videos

[The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure

Likars'Ka Sprava
|March 10, 1998
PubMed

Insights

Combined therapy including glucose-insulin-potassium and glutaminic acid significantly improves cardiovascular function in patients with ischemic heart disease compared to basic therapy alone.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Ischemic heart disease (IHD) presents challenges in managing effort angina and circulatory insufficiency.
  • Functional Class II-III (NYHA) indicates moderate to severe limitations in daily activities due to IHD.

Purpose of the Study:

  • To compare the efficacy of combined therapy versus basic therapy in patients with IHD.
  • To evaluate the impact of glucose-insulin-potassium mixture plus glutaminic acid on cardiohemodynamic interrelations.

Main Methods:

  • Evaluation of 65 patients with ischemic heart disease.
  • Comparative assessment of combined therapy (basic antianginal agents + glucose-insulin-potassium + glutaminic acid) versus basic therapy alone.
  • Assessment of postexercise levels, arterial system coordination, and left ventricular inotropic function.

Main Results:

  • Combined therapy demonstrated superior restoration of cardiohemodynamic interrelations.
  • Significant reduction in postexercise levels was observed with combined therapy.
  • Improved coordination of arterial system function and augmented left ventricular inotropic function were noted.

Conclusions:

  • Combined therapy is more effective than basic therapy for improving cardiovascular function in IHD patients.
  • The addition of glucose-insulin-potassium and glutaminic acid enhances the benefits of standard antianginal treatments.
  • This combined approach offers a promising strategy for managing effort angina and circulatory insufficiency in IHD.

Related Concept Videos